-transparent.png){kind=logo}
Eighteen acetylenic fatty acids were tested as inhibitors of human platelet arachidonic acid 12-lipoxygenase. 4,7,10,13-Eicosatetraynoic (4,7,10,13-ETYA) acid emerged as the most potent compound. Additional experiments have shown that 4,7,10,13-ETYA selectively blocked the 12-lipoxygenase in washed human platelets with lesser activity against the cyclooxygenase. The ID50 value for lipoxygenase was 7.8 microM in comparison with an ID50 of 100 microM for the cyclooxygenase. The commonly used inhibitor 5,8,11,14-eicosatetraynoic acid inhibited both enzymes with equal potency. It appears that 4,7,10,13-ETYA may be a valuable lead for selective modulation of the 12-lipoxygenase pathway in platelet or other target tissues.
F F Sun, and
J C McGuire, and
D R Morton, and
J E Pike, and
H Sprecher, and
W H Kunau
January 1987,
Advances in prostaglandin, thromboxane, and leukotriene research,
F F Sun, and
J C McGuire, and
D R Morton, and
J E Pike, and
H Sprecher, and
W H Kunau
April 1986,
Thrombosis research,
F F Sun, and
J C McGuire, and
D R Morton, and
J E Pike, and
H Sprecher, and
W H Kunau
January 1982,
Methods in enzymology,
F F Sun, and
J C McGuire, and
D R Morton, and
J E Pike, and
H Sprecher, and
W H Kunau
July 1970,
Biochemical and biophysical research communications,
F F Sun, and
J C McGuire, and
D R Morton, and
J E Pike, and
H Sprecher, and
W H Kunau
February 1988,
Biochimica et biophysica acta,
F F Sun, and
J C McGuire, and
D R Morton, and
J E Pike, and
H Sprecher, and
W H Kunau
April 1981,
Biochemical and biophysical research communications,
F F Sun, and
J C McGuire, and
D R Morton, and
J E Pike, and
H Sprecher, and
W H Kunau
August 1984,
Prostaglandins, leukotrienes, and medicine,
F F Sun, and
J C McGuire, and
D R Morton, and
J E Pike, and
H Sprecher, and
W H Kunau
January 1984,
Clinical physiology and biochemistry,
F F Sun, and
J C McGuire, and
D R Morton, and
J E Pike, and
H Sprecher, and
W H Kunau
January 1980,
Advances in prostaglandin and thromboxane research,
F F Sun, and
J C McGuire, and
D R Morton, and
J E Pike, and
H Sprecher, and
W H Kunau
September 2006,
Molecular pharmacology,
